~12 spots leftby Apr 2026

Whitening Serum for Dry Mouth and Bad Breath

Recruiting in Palo Alto (17 mi)
MS
Overseen byMabi Singh, DMD,MS
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Tufts University
Must be taking: Xerostomia-inducing medications
Must not be taking: Whitening products, Desensitizing products
Disqualifiers: Pregnancy, Sjogren's, Autoimmune, others
No Placebo Group
Approved in 2 Jurisdictions

Trial Summary

What is the purpose of this trial?

This trial tests if Crest Daily Whitening Serum can help people with dry mouth and bad breath. The serum aims to make the mouth feel less dry, reduce bad breath, and whiten teeth.

Will I have to stop taking my current medications?

The trial requires participants to be on a stable dose of medications that cause dry mouth, so you should not stop taking your current medications if they meet this criterion.

What data supports the effectiveness of the treatment Crest Whitening Emulsions, Crest Whitening Emulsions, Crest Daily Whitening Serum for dry mouth and bad breath?

The research on emulsions shows that they can improve the absorption of certain compounds, like β-cryptoxanthin and lutein, which might suggest that similar emulsions in the whitening serum could enhance the delivery and effectiveness of its active ingredients.12345

Is the whitening serum safe for use in humans?

The whitening strips containing hydrogen peroxide, like Crest Whitestrips, have been tested in several studies and are generally safe for use, with no significant irritation to oral tissues reported. Additionally, betaine-containing products, which are sometimes used for dry mouth, have shown no adverse effects in studies and are well tolerated.678910

Research Team

MS

Mabi Singh, DMD,MS

Principal Investigator

Tufts University School of Dental Medicine

Eligibility Criteria

This trial is for individuals experiencing dry mouth and bad breath. Specific eligibility criteria are not provided, so it's important to contact the study organizers for detailed information on who can participate.

Inclusion Criteria

I have been on medication that causes dry mouth for 3 months or more.
I am willing to follow the study's treatment plan.
I am 18 years old or older.
See 8 more

Exclusion Criteria

Subjects who are currently pregnant (self-reported)
Unstimulated salivary flow rate of more than 0.18mL/min
I have received radiation therapy in my head or neck area.
See 6 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants use the Crest Daily Whitening Serum for 1 week as described on the label

1 week
Daily use at home

Follow-up

Participants are monitored for safety and effectiveness after treatment

1 week

Treatment Details

Interventions

  • Crest Whitening Emulsions (Other)
Trial OverviewThe trial is testing Crest Whitening Emulsions to see if they help with dry mouth and bad breath over a week of use. It aims to evaluate the effectiveness of this whitening agent in improving these conditions.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
All subjects will be instructed to use the Crest Daily Whitening Serum for 1 week as described on the label. This product is available for purchase at any pharmacy.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Tufts University

Lead Sponsor

Trials
271
Recruited
595,000+

Susan Pandya

Tufts University

Chief Medical Officer

MD from Tufts University School of Medicine

Kenneth Getz profile image

Kenneth Getz

Tufts University

Chief Executive Officer since 2021

MBA from the J.L. Kellogg Graduate School of Management at Northwestern University, BA from Brandeis University

Findings from Research

The self-double-emulsifying drug delivery system (SDEDDS) significantly enhances the oral absorption of hydroxysafflor yellow A (HSYA), a compound with low bioavailability, by forming stable double emulsions in the gastrointestinal environment.
While SDEDDS improves absorption, it also causes some mucosal damage in the rat intestine, indicating a need for future formulation adjustments to enhance safety while maintaining efficacy.
Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studies.Lv, LZ., Tong, CQ., Lv, Q., et al.[2021]
In a 4-month study involving 18 healthy volunteers, daily supplementation of 15 mg of lutein significantly increased serum lutein levels by five times within the first month, indicating effective absorption and bioavailability.
The study identified lutein monopalmitate and another unidentified ester in serum for the first time, suggesting a potential 'ceiling effect' on lutein transport, although no adverse health effects were observed during the trial.
Lutein ester in serum after lutein supplementation in human subjects.Granado, F., Olmedilla, B., Gil-Martínez, E., et al.[2022]
Incorporating peptide antigens into soybean emulsions during the formulation stage (either oil-in-water or water-in-oil-in-water) effectively induced high levels of cytotoxic T lymphocyte (CTL) responses in mice, while adding peptide to a pre-formed emulsion did not stimulate any response.
The study found that the induction of CTL activity was linked to the dispersion of the peptide in the oil phase and a negative zeta potential, rather than the size of the emulsion globules, highlighting the importance of how the peptide is incorporated into the emulsion.
CTL induction using synthetic peptides delivered in emulsions--critical role of the formulation procedure.Singh, M., Hioe, C., Qiu, H., et al.[2023]

References

Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studies. [2021]
Lutein ester in serum after lutein supplementation in human subjects. [2022]
CTL induction using synthetic peptides delivered in emulsions--critical role of the formulation procedure. [2023]
In vivo and in vitro studies on the absorption characteristics of β-cryptoxanthin in the intestine. [2014]
Effect of the emulsifier type on the physicochemical stability and in vitro digestibility of a lutein/zeaxanthin-enriched emulsion. [2022]
Effects of a betaine-containing toothpaste on subjective symptoms of dry mouth: a randomized clinical trial. [2018]
Professional vital bleaching using a thin and concentrated peroxide gel on whitening strips: an integrated clinical summary. [2013]
A new approach to strip-based tooth whitening: 14% hydrogen peroxide delivered via controlled low dose. [2018]
Betaine-containing toothpaste relieves subjective symptoms of dry mouth. [2019]
The effects of two sodium lauryl sulphate-containing toothpastes with and without betaine on human oral mucosa in vivo. [2013]